Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-125575
Filing Date
2025-12-29
Accepted
2025-12-29 06:03:50
Documents
2
Period of Report
2025-12-29

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0271068-6k_canfite.htm 6-K 11277
2 PRESS RELEASE DATED DECEMBER 26, 2025 ea027106801ex99-1_canfite.htm EX-99.1 11846
  Complete submission text file 0001213900-25-125575.txt   24144
Mailing Address 26 BEN GURION STREET RAMAT GAN L3 5257346
Business Address 26 BEN GURION STREET RAMAT GAN L3 5257346 972 39241114
Can-Fite BioPharma Ltd. (Filer) CIK: 0001536196 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36203 | Film No.: 251602357
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)